ASAP Act Aims to Expand Medicare Coverage for Alzheimer's Blood Tests

A bipartisan federal bill modeled after mammogram success would remove a major access barrier by covering blood-based biomarkers for Alzheimer's under Medicare. State-level efforts in Delaware and Oregon also progressing. A new practical guide details costs ($300–$1,500) and insurance tips.